FOLH1 and prostate carcinoma: PSMA-targeted PET imaging has a higher sensitivity and specificity for the detection of primary prostate carcinoma when compared to MRI, and limited results suggest that it may aid in clinical decision-making by eliminating the further need for biopsies.